ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis

Wang, Tongyu; Tan, Wenting; Wang, Xianbo; Zheng, Xin; Huang, Yan; Li, Beiling; Meng, Zhongji; Gao, Yanhang; Qian, Zhiping; Liu, Feng; Lu, Xiaobo; Yan, Huadong; Zheng, Yubao; Zhang, Weituo; Yin, Shan; Gu, Wenyi; Zhang, Yan; Dong, Fuchen; Wei, Jianyi; Deng, Guohong; Xiang, Xiaomei; Zhou, Yi; Hou, Yixin; Zhang, Qun; Xiong, Shue; Liu, Jing; Long, Liyuan; Chen, Ruochan; Chen, Jinjun; Jiang, Xiuhua; Luo, Sen; Chen, Yuanyuan; Jiang, Chang; Zhao, Jinming; Ji, Liujuan; Mei, Xue; Li, Jing; Li, Tao复旦大学; 华中科技大学; 吉林大学; 南方医科大学; 南开大学; 山东大学; 上海交通大学; 浙江大学; 中山大学; 中国科学院研究生院; 1; y
JHEP REPORTS2022-10DOI: 10.1016/j.jhepr.2022.100529
7被引7阅读
引用收藏
分享

摘要

Background & Aims: Pre-acute-on-chronic liver failure (ACLF) is a distinct intermediate stage between acute decompensation (AD) and ACLF. However, identifying patients with pre-ACLF and predicting progression from AD to ACLF is difficult. This study aimed to identify pre-ACLF within 28 days, and to develop and validate a prediction model for ACLF in patients with HBV-related decompensated cirrhosis. @@@ Methods: In total, 1,736 patients with HBV-related cirrhosis and AD were enrolled from 2 large-scale, multicenter, prospective cohorts. ACLF occurrence within 28 days, readmission, and 3-month and 1-year outcomes were collected. @@@ Results: Among 970 patients with AD without ACLF in the derivation cohort, the 94 (9.6%) patients with pre-ACLF had the highest 3-month and 1-year LT-free mortality (61.6% and 70.9%, respectively), which was comparable to those with ACLF at enrollment (57.1% and 67.1%); the 251 (25.9%) patients with unstable decompensated cirrhosis had mortality rates of 22.4% and 32.1%, respectively; while the 507 (57.9%) patients with stable decompensated cirrhosis had the best outcomes (1-year mortality rate of 2.6%). Through Cox proportional hazard regression, specific precipitants, including hepatitis B flare with HBV reactivation, spontaneous hepatitis B flare with high viral load, superimposed infection on HBV, and bacterial infection, were identified to be significantly associated with ACLF occurrence in the derivation cohort. A model that incorporated precipitants, indicators of systemic inflammation and organ injuries reached a high C-index of 0.90 and 0.86 in derivation and validation cohorts, respectively. The optimal cut-off value (0.22) differentiated high-risk and low-risk patients, with a negative predictive value of 0.95. @@@ Conclusions: Three distinct clinical courses of patients with AD are validated in the HBV-etiology population. The precipitants significantly impact on AD-ACLF transition. A model developed by the precipitant-systemic inflammation-organ injury framework could be a useful tool for predicting ACLF occurrence. @@@ Lay summary: It was previously shown that patients with decompensated cirrhosis could be stratified into 3 groups based on their short-term clinical prognoses. Herein, we showed that this stratification applies to patients who develop cirrhosis as a result of hepatitis B virus infection. We also developed a precipitant-based model (i.e. a model that incorporated information about the exact cause of decompensation) that could predict the likelihood of these patients developing a very severe liver disease called acute-on-chronic liver failure (or ACLF).

学科与关键词

关键词
acutely decompensated cirrhosisacute-on-chronic liver failurehepatitis B virusprecipitantsprediction model
相关
加载中…
  • Prognosis prediction performs better in patients with non-cirrhosis hepatitis B virus-related acute-on-chronic liver failure than those with cirrhosis
    Yu, Xia; Li, Hai; Tan, Wenting; Wang, Xianbo; Zheng, Xin; Huang, Yan; Li, Beiling; Meng, Zhongji; Gao, Yanhang; Qian, Zhiping; Liu, Feng; Lu, Xiaobo; Shang, Jia; Yan, Huadong; Zheng, Yubao; Zhang, Weituo; Yin, Shan; Gu, Wenyi; Deng, Guohong; Xiang, Xiaomei; Zhou, Yi; Hou, Yixin; Zhang, Qun; Xiong, Shue; Liu, Jing; Chen, Ruochan; Long, Liyuan; Chen, Jinjun; Jiang, Xiuhua; Luo, Sen; Chen, Yuanyuan; Jiang, Chang; Zhao, Jinming; Ji, Liujuan; Mei, Xue; Li, Jing; Li, Tao; Zheng, RongjiongFrontiers in Microbiology, 2022, 13: 1013439.被引 1
  • MELD score < 18 rule out 28-day ACLF development among inpatients with hepatitis B-related previous compensated liver disease
    Qi, Tingting; Zhu, Congyan; Wang, Jiapeng; Li, Beiling; Huang, Zuxiong; Zhu, Zhibin; Tu, Minghan; Deng, Guohong; Zheng, Xin; Huang, Yan; Meng, Zhongji; Wang, Xianbo; Qian, Zhiping; Li, Hai*; Gao, Yanhang; Liu, Feng; Shang, Jia; Shi, Yu; Lu, Xiaobo; Wang, Shaoyang; Chen, Jinjun*Journal of Viral Hepatitis, 2022, 29(12): 1089-1098.
  • Tri-typing of hepatitis B-related acute-on-chronic liver failure defined by the World Gastroenterology Organization
    Tang, Xiaoting; Qi, Tingting; Li, Beiling; Li, Hai; Huang, Zuxiong; Zhu, Zhibin; Tu, Minghan; Gao, Jie; Zhu, Congyan; Jiang, Xiuhua; Yu, Xutong; Lu, Guanting; Xiong, Ming; He, Qinjun; Zhou, Fuyuan; Wen, Weiqun; Chen, Jinjun*; Hou, JinlinJournal of Gastroenterology and Hepatology, 2021, 36(1): 208-216.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
JHEP REPORTS
发表日期
2022-10
卷期
第 4 卷, 第 10 期
页码
100529
DOI
10.1016/j.jhepr.2022.100529
成果收录
SCIE
资助标注
Shanghai Hospital Development Commission [SHDC2020CR1037B]; National Key R&D Program of China [2017YFC0908100]; National Science and Technology Major Project [2018ZX10302206, 2018ZX10723203, 2017ZX10202202]; National Natural Science Foundation of China [8217032461, 82170629, 81930061, 81900579, 81970550, 82070613, 82070650, 81972265, 81870425, 81774234]; Chongqing Natural Science Foundation [CSTC2019jcyj-zdxmX0004]; Beijing Municipal Science & Technology Commission [Z191100006619033]; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01S131]; Clinical Research Program of Nanfang Hospital, Southern Medical University [2018CR037, 2020CR026]; High-level University Construction Funding of Guangdong Provincial Department of Education [LC2019ZD006]; President Foundation of Nanfang Hospital, Southern Medical University [2019Z003]; Foundation for Innovative Research Groups of Hubei Provincial Natural Science Foundation [2018CFA031]; Hubei Province's Outstanding Medical Academic Leader Program and Project of Hubei University of Medicine [FDFR201902, 2020XGFYZR05]; Fundamental Research Funds for the Central Universities [2021FZZX001-41]; Guangdong Basic and Applied Basic Research Foundation [2020A1515010052]; Natural Fund of Guangdong Province [2016A030313237]; Guangzhou City Science and Technology Project [201607010064]; Shanghai Municipal Education Commission-Guofeng Clinical Medicine Grant Support

作者

  • W

    Wang, Tongyu (第一作者)

    shanghai jiao tong univ

  • T

    Tan, Wenting

    third mil med univ

查看全部 43 位作者收起作者
  • W

    Wang, Xianbo

    beijing ditan hosp · capital med univ

  • Z

    Zheng, Xin

    huazhong univ sci & technol

  • H

    Huang, Yan

  • L

    Li, Beiling

    southern med univ

  • M

    Meng, Zhongji

    hubei univ med

  • G

    Gao, Yanhang

    jilin univ

  • Q

    Qian, Zhiping

    fudan univ

  • L

    Liu, Feng

    2 · nankai univ · shandong univ

  • L

    Lu, Xiaobo

    1 · xinjiang med univ

  • Y

    Yan, Huadong

  • Z

    Zheng, Yubao

    sun yat sen univ

  • Z

    Zhang, Weituo

    shanghai jiao tong univ

  • Y

    Yin, Shan

    shanghai jiao tong univ

  • G

    Gu, Wenyi

    shanghai jiao tong univ · 1

  • Z

    Zhang, Yan

    shanghai jiao tong univ

  • D

    Dong, Fuchen

    shanghai jiao tong univ

  • W

    Wei, Jianyi

    shanghai jiao tong univ

  • D

    Deng, Guohong

    third mil med univ

  • X

    Xiang, Xiaomei

    third mil med univ

  • Z

    Zhou, Yi

    third mil med univ

  • H

    Hou, Yixin

    beijing ditan hosp · capital med univ

  • Z

    Zhang, Qun

    beijing ditan hosp · capital med univ

  • X

    Xiong, Shue

    huazhong univ sci & technol

  • L

    Liu, Jing

  • L

    Long, Liyuan

  • C

    Chen, Ruochan

  • C

    Chen, Jinjun

    southern med univ

  • J

    Jiang, Xiuhua

    southern med univ

  • L

    Luo, Sen

    hubei univ med

  • C

    Chen, Yuanyuan

    hubei univ med

  • J

    Jiang, Chang

    jilin univ

  • Z

    Zhao, Jinming

    jilin univ

  • J

    Ji, Liujuan

    fudan univ

  • M

    Mei, Xue

    fudan univ

  • L

    Li, Jing

  • L

    Li, Tao

    2 · shandong univ

  • Z

    Zheng, Rongjiong

    1 · xinjiang med univ

  • Z

    Zhou, Xinyi

    1 · xinjiang med univ

  • R

    Ren, Haotang

  • S

    Shi, Yu

  • L

    Li, Hai

    shanghai jiao tong univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417